NCT04708184View on ClinicalTrials.gov

A Study to Assess Relative Bioavailability of and Effect of Food on a New Oral Tablet Formulation of GLPG3970

PHASE1CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

January 11, 2021

Primary Completion Date

February 25, 2021

Study Completion Date

February 25, 2021

Conditions
Healthy
Interventions
DRUG

GLPG3970 oral solution

GLPG3970 for oral administration

DRUG

GLPG3970 tablet

GLPG3970 for oral administration

Trial Locations (1)

35042

Biotral Rennes, Rennes

Sponsors

Lead Sponsor

Galapagos NV
All Listed Sponsors
lead

Galapagos NV

INDUSTRY